ADIA reports 5.9% stake in Medline Inc.
Medline Inc. received a Schedule 13G showing a significant ownership position by Abu Dhabi Investment Authority (ADIA) and its subsidiary Platinum Falcon B 2018 RSC Limited.
Rhea-AI Filing Summary
Medline Inc. received a Schedule 13G showing a significant ownership position by Abu Dhabi Investment Authority (ADIA) and its subsidiary Platinum Falcon B 2018 RSC Limited. ADIA reports beneficial ownership of 47,515,277 shares of Medline Class A common stock, representing 5.9% of the outstanding class.
Within this amount, Platinum Falcon directly owns 46,998,036 Class A shares, representing 5.8% of the class, while ADIA directly owns 517,241 Class A shares. The reported percentages are based on 811,418,179 Class A shares outstanding as of December 18, 2025, as disclosed in Medline’s prospectus.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Medline Inc. (MDLN) is reported in this Schedule 13G?
Who are the reporting persons on this Medline Inc. (MDLN) Schedule 13G filing?
What class of Medline Inc. (MDLN) securities is covered by this Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.